ASML Holding Down Nearly 7%, on Pace for Largest Percent Decrease Since June 2022 — Data Talk
ASML Holding NV ADR (ASML) is currently at $910.70, down $66.21 or 6.78%
--Would be lowest close since Feb. 21, 2024, when it closed at $908.21
--On pace for largest percent decrease since June 16, 2022, when it fell 7.36%
--Currently down three of the past four days
--Down 6.16% month-to-date
--Up 20.32% year-to-date
--Down 13.05% from its all-time closing high of $1047.39 on March 7, 2024
--Up 46.04% from 52 weeks ago (April 19, 2023), when it closed at $623.60
--Down 13.05% from its 52-week closing high of $1047.39 on March 7, 2024
--Up 59.6% from its 52-week closing low of $570.60 on Oct. 3, 2023
--Traded as low as $904.73; lowest intraday level since Feb. 21, 2024, when it hit $892.63
--Down 7.39% at today's intraday low; largest intraday percent decrease since Oct. 13, 2022, when it fell as much as 8.83%
--Second worst performer in the Nasdaq 100 today
All data as of 10:32:42 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 17, 2024 10:50 ET (14:50 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure